Concepedia
Statistics
Publications
29
Citations
1.7K
H-Index
22
Active since
2002
Affiliations
Novartis (Switzerland)(Current)
Novartis (United States)
University of Nebraska Medical Center
Novartis (India)
Nebraska Medical Center
Surya Ayalasomayajula is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and pharmacotherapy.
Top concepts
MedicinePharmacologyPharmacotherapyOphthalmologyPharmacokineticsHypertensionOxidative StressPhysiologyDrug DiscoveryVascular Biology
Publications per year
2002–2018
Subconjunctival Nano- and Microparticles Sustain Retinal Delivery of Budesonide, a Corticosteroid Capable of Inhibiting VEGF Expression
Uday B. Kompella, Nagesh Bandi, Surya Ayalasomayajula · Investigative Ophthalmology & Visual Science · 2003 · 239 citations · Full text
Single Periocular Injection of Celecoxib-PLGA Microparticles Inhibits Diabetes-Induced Elevations in Retinal PGE<sub>2</sub>, VEGF, and Vascular Leakage
Aniruddha Amrite, Surya Ayalasomayajula, N. Cheruvu et al. · Investigative Ophthalmology & Visual Science · 2006 · 163 citations
Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model
Surya Ayalasomayajula, Uday B. Kompella · European Journal of Pharmacology · 2002 · 151 citations
Vascular Leakage, Ocular Disease, Ophthalmology +9
Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function
Catherine E. Watson, Nicole Weissbach, Lise Kjems et al. · Journal of Lipid Research · 2010 · 147 citations · Full text
Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model
Surya Ayalasomayajula, Uday B. Kompella · European Journal of Pharmacology · 2005 · 137 citations
Optogenetics, Ocular Disease, Retina +9
1–5 of 29